Ryan T Sullivan - Net Worth and Insider Trading

Ryan T Sullivan Net Worth

The estimated net worth of Ryan T Sullivan is at least $711,787 dollars as of 2024-03-19. Ryan T Sullivan is the General Counsel and Secretary of Intercept Pharmaceuticals Inc and owns about 21,889 shares of Intercept Pharmaceuticals Inc (ICPT) stock worth over $415,891. Ryan T Sullivan is also the EVP and General Counsel of Anacor Pharmaceuticals Inc and owns about 30,132 shares of Anacor Pharmaceuticals Inc (ANAC) stock worth over $295,896. Details can be seen in Ryan T Sullivan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ryan T Sullivan has not made any transactions after 2019-11-19 and currently still holds the listed stock(s).

Transaction Summary of Ryan T Sullivan

To

Ryan T Sullivan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ryan T Sullivan owns 2 companies in total, including Intercept Pharmaceuticals Inc () , and Anacor Pharmaceuticals Inc () .

Click here to see the complete history of Ryan T Sullivan’s form 4 insider trades.

Insider Ownership Summary of Ryan T Sullivan

Ticker Comapny Transaction Date Type of Owner
Intercept Pharmaceuticals Inc 2019-11-19 General Counsel and Secretary
Anacor Pharmaceuticals Inc 2016-06-24 EVP and General Counsel

Ryan T Sullivan Latest Holdings Summary

Ryan T Sullivan currently owns a total of 2 stocks. Among these stocks, Ryan T Sullivan owns 21,889 shares of Intercept Pharmaceuticals Inc (ICPT) as of November 19, 2019, with a value of $415,891 and a weighting of 58.43%. Ryan T Sullivan also owns 30,132 shares of Anacor Pharmaceuticals Inc (ANAC) as of April 29, 2016, with a value of $295,896 and a weighting of 41.57%.

Latest Holdings of Ryan T Sullivan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ICPT Intercept Pharmaceuticals Inc 2019-11-19 21,889 19.00 415,891
ANAC Anacor Pharmaceuticals Inc 2016-04-29 30,132 9.82 295,896

Holding Weightings of Ryan T Sullivan


Ryan T Sullivan Form 4 Trading Tracker

According to the SEC Form 4 filings, Ryan T Sullivan has made a total of 2 transactions in Intercept Pharmaceuticals Inc (ICPT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Intercept Pharmaceuticals Inc is the sale of 12,154 shares on November 19, 2019, which brought Ryan T Sullivan around $1 Million.

According to the SEC Form 4 filings, Ryan T Sullivan has made a total of 0 transactions in Anacor Pharmaceuticals Inc (ANAC) over the past 5 years. The most-recent trade in Anacor Pharmaceuticals Inc is the sale of 3,125 shares on April 29, 2016, which brought Ryan T Sullivan around $207,281.

Insider Trading History of Ryan T Sullivan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ryan T Sullivan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Ryan T Sullivan Ownership Network

Ownership Network List of Ryan T Sullivan

No Data

Ownership Network Relation of Ryan T Sullivan


Ryan T Sullivan Owned Company Details

What does Intercept Pharmaceuticals Inc do?

Who are the key executives at Intercept Pharmaceuticals Inc?

Ryan T Sullivan is the General Counsel and Secretary of Intercept Pharmaceuticals Inc. Other key executives at Intercept Pharmaceuticals Inc include EVP & Chief Financial Officer Andrew Saik , President & R&D and CMO M Michelle Berrey , and Chief Accounting Officer Rocco Venezia .

Intercept Pharmaceuticals Inc () Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Intercept Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Intercept Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Intercept Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Intercept Pharmaceuticals Inc Insider Transactions

No Available Data

Ryan T Sullivan Mailing Address

Above is the net worth, insider trading, and ownership report for Ryan T Sullivan. You might contact Ryan T Sullivan via mailing address: C/o Warner Chilcott Corporation, 100 Enterprise Drive, Rockaway Nj 07855.

Discussions on Ryan T Sullivan

No discussions yet.